Zinger Key Points
- SpringWorks Therapeutics shares are trading lower after the company announced the pricing of a public offering.
- This offering involves selling approximately 9.48 million shares of its common stock at $29.00 per share.
- Feel unsure about the market’s next move? Copy trade alerts from Matt Maley—a Wall Street veteran who consistently finds profits in volatile markets. Claim your 7-day free trial now.
SpringWorks Therapeutics Inc SWTX shares are trading lower by 8.4% to $29.00 Tuesday morning after the company announced the pricing of a public offering.
This offering involves selling approximately 9.48 million shares of its common stock at $29.00 per share, totaling an expected gross proceeds of about $275.0 million before expenses. The company expects to close the offering around December 7, pending standard closing conditions.
Additionally, SpringWorks has granted underwriters an option to purchase an additional 1.42 million shares within 30 days at the same offering price, minus discounts and commissions.
See Also: SpringWorks Therapeutics Announces Pricing of Upsized Public Offering of Common Stock
According to data from Benzinga Pro, SWTX has a 52-week high of $34.16 and a 52-week low of $18.00.
Edge Rankings
Price Trend
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.